Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Osteoinduction by ex vivo adenovirus-mediated BMP2 delivery is independent of cell type.

Osteoinduction by ex vivo adenovirus-mediated BMP2 delivery is independent of cell type. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Osteoinduction by ex vivo adenovirus-mediated BMP2 delivery is independent of cell type. Abstract Text:

    z gugalaZ Gugala,e a olmsted-davisE A Olmsted-Davis,f h gannonF H Gannon,r w lindseyR W Lindsey,a r davisA R Davis,

    The objective of the study was to analyze and compare the abilities of various human cell types with inherently dissimilar osteogenic potentials to induce heterotopic bone formation following ex vivo transduction with two distinct adenoviral vectors encoding bone morphogenetic protein type 2 (BMP2). The cells comprised primary human bone marrow mesenchymal stem cells (BM-MSCs), primary human skin fibroblasts (SFs), and a human diploid fetal lung cell line (MRC-5). The vectors included adenovirus type 5 or a chimeric adenovirus type 5 with the fiber gene of adenovirus type 35 (Ad5F35-BMP2), both demonstrating significantly different expression of BMP2 in vitro. The experimental groups consisted of the three human cell types transduced with each of the two adenoviral vectors. Using nonobese diabetic severe combined immunodeficiency (NOD/SCID) mice, the transduced cells were injected intramuscularly following ex vivo adenoviral transduction. The nature and extent of heterotopic bone formation were analyzed radiographically and histologically. At 14 days postinjection, abundant, highly mineralized bone was formed in mice injected with Ad5F35-BMP2-transduced cells irrespective of the cell type. There was no statistically significant difference in the amount of bone formed between BM-MSCs, SFs, and MRC-5 cells transduced with Ad5F35-BMP2, as assessed from bone surface area on biplanar plain radiography. Substantially lesser amounts or no bone could be detected in mice injected with cells transduced with Ad5-BMP2. Immunohistochemical analysis confirmed the presence of human cells in muscle as early as 2 days postdelivery; however, at 6-7 days after injection, the transduced cells could not be detected in surrounding muscle, or in the heterotopic bone, indicating the host origin of the newly formed bone. The results of the study demonstrate no significant difference in osteoinductive properties between BM-MSCs, SFs, and MRC-5 cells transduced ex vivo with the same type of adenovirus encoding BMP2. The level of BMP2 expression appears to be a crucial factor determining the extent of heterotopic bone formation and was significantly affected by the type of adenovirus used. In the cell types studied, Ad5F35-BMP2 was more efficacious than Ad5-BMP2 in providing adequate levels of BMP2 for efficient osteoinduction.

    Osteoinduction by ex vivo adenovirus-mediated BMP2 delivery is independent of cell type. Publishing Authors By Initials

    z gugalaZ Gugala,ea olmsted-davisEA Olmsted-Davis,fh gannonFH Gannon,rw lindseyRW Lindsey,ar davisAR Davis,

    For similar peptides: intercellular signaling peptides and proteins: cytokines: transforming growth factor beta research abstracts see: peptides: intercellular signaling peptides and proteins: cytokines: transforming growth factor beta research

    PUBMED ID PMID:

    MEDLINE DATE:

    Osteoinduction by ex vivo adenovirus-mediated BMP2 delivery is independent of cell type. Journal Published:

    PUBLICATION TYPE: Research Support, U.S. Gov't,

    Journal: Gene therapy

    VOLUME: 10

    Page Numbers: 1289-96

    Journal Abbreviation: Gene Ther.

    ISSN: 0969-7128

    DAY: 19

    MONTH: Aug

    YEAR: 2003

    Osteoinduction by ex vivo adenovirus-mediated BMP2 delivery is independent of cell type. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9421525

    Osteoinduction by ex vivo adenovirus-mediated BMP2 delivery is independent of cell type. Keywords Mesh Terms:

    KEYWORDS: Transforming Growth Factor beta

    MESH TERMS: methods

    Chemical & Substance for Abstract: Osteoinduction by ex vivo adenovirus-mediated BMP2 delivery is independent of cell type. Information

    Substance Name: bone morphogenetic protein 2

    Registry Number: 0

    Grant and Affiliation Information for Osteoinduction by ex vivo adenovirus-mediated BMP2 delivery is independent of cell type.

    AFFILIATION: Department of Orthopaedic Surgery, Baylor College of Medicine, Houston, TX, USA.

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY: United States NIAMS

    GRANT: R21AR484-01

    ACRONYM: AR

    MEDLINETA: Gene Ther

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Osteoinduction by ex vivo adenovirus-mediated BMP2 delivery is independent of cell type Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News